Gossamer Bio, Inc. (GOSS)
0.1699
0.00 (0.00%)
USD |
NASDAQ |
Aug 28, 11:25
Gossamer Bio EPS Diluted (TTM) : -0.6959 for June 30, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.6959 |
| March 31, 2026 | -0.7877 |
| December 31, 2025 | -0.7499 |
| September 30, 2025 | -0.6872 |
| June 30, 2025 | -0.6118 |
| March 31, 2025 | -0.237 |
| December 31, 2024 | -0.2612 |
| September 30, 2024 | -0.329 |
| June 30, 2024 | -0.4003 |
| March 31, 2024 | -1.052 |
| December 31, 2023 | -1.384 |
| September 30, 2023 | -1.762 |
| June 30, 2023 | -2.206 |
| March 31, 2023 | -2.497 |
| December 31, 2022 | -2.740 |
| September 30, 2022 | -2.894 |
| June 30, 2022 | -3.046 |
| March 31, 2022 | -3.110 |
| Date | Value |
|---|---|
| December 31, 2021 | -3.127 |
| September 30, 2021 | -3.265 |
| June 30, 2021 | -3.262 |
| March 31, 2021 | -3.465 |
| December 31, 2020 | -3.560 |
| September 30, 2020 | -3.571 |
| June 30, 2020 | -3.569 |
| March 31, 2020 | -3.303 |
| December 31, 2019 | -3.327 |
| September 30, 2019 | -3.024 |
| June 30, 2019 | -2.975 |
| March 31, 2019 | -2.734 |
| December 31, 2018 | -2.231 |
| September 30, 2018 | -1.740 |
| June 30, 2018 | -0.9944 |
| March 31, 2018 | -0.4975 |
| December 31, 2017 | -0.1023 |
| September 30, 2017 | -0.0044 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| United Therapeutics Corp. | 27.96 |
| Arbutus Biopharma Corp. | 0.7834 |
| Kura Oncology, Inc. | -3.362 |
| ACADIA Pharmaceuticals, Inc. | 2.220 |
| Alnylam Pharmaceuticals, Inc. | 5.923 |